Last updated on November 2017

SYNERGY


Brief description of study

SYNERGY

Detailed Study Description

A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multi-center Study to Evaluate the Efficacy, Safety and Tolerability of Combinations of Solifenacin Succinate and Mirabegron Compared to Solifenacin Succinate and Mirabegron Monotherapy in the Treatment of Overactive Bladder

Clinical Study Identifier: TX81369

Contact Investigators or Research Sites near you

Start Over

Christina Wegerski

Urology Group of New Mexico
Albuquerque, NM USA

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.